Dr. Moses David Salgado, MD

Dr. Salgado practices at Pacific ENT Medical Group, Inc. in Carlsbad, California.

Dr. Salgado's NPI, 1235345489, was assigned on May 15, 2007. Dr. Salgado graduated from UC Davis School of Medicine in 2005. Dr. Salgado holds California license A98797.

Dr. Salgado's primary practice is Pacific ENT Medical Group, Inc., at 6010 Hidden Valley Rd, Carlsbad, CA 92011 in San Diego County. The practice phone is (858) 755-9343.

Dr. Salgado's primary practice is Pacific ENT Medical Group, Inc. in Carlsbad, California. Dr. Salgado is also affiliated with Scripps Memorial Hospital La Jolla. The medical group on file is Pacific ENT Medical Group. Dmand AI also links Dr. Salgado to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Salgado practices, 3 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Salgado's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Salgado is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dr. Salgado is licensed in California.

Dmand AI lists acute sinusitis, chronic ear infection, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery and hearing loss and impairment among the conditions Dr. Salgado treats.

CMS data shows 1,062 Medicare services from Dr. Salgado across 8 procedure codes in 2024, for 439 Medicare patients. Medicare paid $85,367 for them. Every service was in an office.

CMS counts 439 Medicare patients who saw Dr. Salgado in 2024. The largest group is 65 to 74, with 199 patients. 74% of them have high cholesterol, and 58% have high blood pressure. Their average risk score is 1.03, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Salgado's median patient age at 59, with 52% women.

In 2024, Dr. Salgado wrote 663 Medicare Part D claims for 222 patients. 94% of them were for generic drugs. CMS names the drug for 558 of them, across 18 drugs with 11 or more claims each, at $61,518 in total drug cost. In 2023, CMS named 382 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Salgado for performance year 2024, reported individually. Dr. Salgado accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Salgado as offering telehealth.

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Salgado in 2013. Dr. Salgado's most frequent co-authors are Peter Charles Belafsky, MD, PhD, Hugh B. Black, MD and Hilary Alan Brodie, MD.

CMS Open Payments shows 109 general payments to Dr. Salgado from 21 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 65% of the total. Intersect ENT, Inc. paid the most, $2,195.

Dmand AI lists 1 award for Dr. Salgado, most recently CMS Stage 1 EHR in 2012.

Dr. Salgado graduated from UC Davis School of Medicine in 2005.

Dr. Salgado is in network with 15 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.